Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India

US Food and Drug Administration conducted the inspection at Halol plant during June 3-11, 2019 and issued four observations.

Drug firm Cadila Healthcare on Friday reported a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019.

The growing popularity of Patanjali's products has caused discomfort among the firm's international rivals who are out to malign it by spreading lies, yoga guru Ramdev's company said on Tuesday.

The process of connecting man and the machine include an invasive and a non-invasive method. The former involves an implant that directly touches the human brain and the latter involves electrodes placed near the human skin

The U.S. Food and Drug Administration (FDA) said it found adulteration and \"significant violations\" of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd's plant in Puducherry in south India.

The US Food and Drug Administration (FDA) inspected UBL's Panvel plant in Mumbai last August and filed an Establishment Inspection Report (EIR) that listed concerns such as birds faeces on packages of beer cans and potential contamination sources

This plant had five USFDA inspections between March 2015 and September 2018 with no observations and receiving an EIR after each inspection visit

Analysts say deals have dried up as MNCs no longer view India as a safe haven to invest, despite its potential

Drug regulatory reforms in China have turned the heat on the Indian pharmaceutical industry and raised the cost of bulk drugs. But some firms have managed to turn the crisis into an opportunity by filling in the space left by the Chinese.

Share Market LIVE: On the sectoral front, indices trading in the green are IT, FMCG, Auto, Metal, Infra and Pharma. In declining indices, PSU bank and Media tops the list with 1.40% decline each, followed by Financial services, Energy, Bank and Realty.